tiprankstipranks
Advertisement
Advertisement

BRNS Stock Latest News

Barinthus Biotherapeutics Holds 2026 Annual General Meeting
Company AnnouncementsBarinthus Biotherapeutics Holds 2026 Annual General Meeting
1M ago
8K
BRNS
Barinthus Biotherapeutics Shareholders Approve Scheme of Arrangement
PremiumCompany Announcements
Barinthus Biotherapeutics Shareholders Approve Scheme of Arrangement
2M ago
8K
BRNS
Analyst Flags High Risk in Barinthus Biotherapeutics’ Forward-Looking Statements and Guidance Reliability
PremiumCompany Announcements
Analyst Flags High Risk in Barinthus Biotherapeutics’ Forward-Looking Statements and Guidance Reliability
3M ago
BRNS
Barinthus’ VTP-300 Hepatitis B Study Reaches Completion: What Investors Should Watch Next
PremiumCompany Announcements
Barinthus’ VTP-300 Hepatitis B Study Reaches Completion: What Investors Should Watch Next
3M ago
BRNS
Barinthus Biotherapeutics appoints Douglas Swirsky as CFO
PremiumCompany Announcements
Barinthus Biotherapeutics appoints Douglas Swirsky as CFO
3M ago
8K
BRNS
Barinthus Biotherapeutics Announces Upcoming Accounting Leadership Change
PremiumCompany AnnouncementsBarinthus Biotherapeutics Announces Upcoming Accounting Leadership Change
4M ago
8K
BRNS
Barinthus Bio Announces 2025 Results and Clywedog Merger
Premium
Company Announcements
Barinthus Bio Announces 2025 Results and Clywedog Merger
5M ago
8K
BRNS
Barinthus Biotherapeutics reports FY25 EPS ($1.64) vs ($1.55) last year
Premium
The Fly
Barinthus Biotherapeutics reports FY25 EPS ($1.64) vs ($1.55) last year
5M ago
BRNS
Barinthus Biotherapeutics Amends Cross-Border Merger Agreement Terms
PremiumCompany Announcements
Barinthus Biotherapeutics Amends Cross-Border Merger Agreement Terms
5M ago
8K
BRNS
Barinthus Biotherapeutics Receives Nasdaq Minimum Bid Price Notice
PremiumCompany Announcements
Barinthus Biotherapeutics Receives Nasdaq Minimum Bid Price Notice
7M ago
8K
BRNS
Promising Clinical Trial Results and Strategic Merger Drive Buy Rating for Barinthus Biotherapeutics
PremiumRatings
Promising Clinical Trial Results and Strategic Merger Drive Buy Rating for Barinthus Biotherapeutics
8M ago
BRNS
Barinthus Biotherapeutics Updates on AVALON Trial Progress
PremiumCompany Announcements
Barinthus Biotherapeutics Updates on AVALON Trial Progress
8M ago
8K
BRNS
Barinthus Biotherapeutics announces update on Phase 1 trial of VTP-1000
PremiumThe FlyBarinthus Biotherapeutics announces update on Phase 1 trial of VTP-1000
8M ago
BRNS
Buy Rating for Barinthus Biotherapeutics: Promising Clinical Developments and Strategic Merger with Clywedog Therapeutics
Premium
Ratings
Buy Rating for Barinthus Biotherapeutics: Promising Clinical Developments and Strategic Merger with Clywedog Therapeutics
9M ago
BRNS
Barinthus Biotherapeutics price target raised to $4 from $3 at H.C. Wainwright
Premium
The Fly
Barinthus Biotherapeutics price target raised to $4 from $3 at H.C. Wainwright
9M ago
BRNS
Barinthus Biotherapeutics Reports Q3 2025 Earnings
PremiumCompany Announcements
Barinthus Biotherapeutics Reports Q3 2025 Earnings
9M ago
BRNS
Barinthus Biotherapeutics reports Q3 EPS (36c) vs (21c) last year
PremiumThe Fly
Barinthus Biotherapeutics reports Q3 EPS (36c) vs (21c) last year
9M ago
BRNS
Barinthus Biotherapeutics Advances Celiac Disease Treatment with VTP-1000 Trial
PremiumCompany Announcements
Barinthus Biotherapeutics Advances Celiac Disease Treatment with VTP-1000 Trial
9M ago
BRNS
Barinthus Biotherapeutics Announces Merger with Clywedog Therapeutics
PremiumCompany Announcements
Barinthus Biotherapeutics Announces Merger with Clywedog Therapeutics
10M ago
8K
BRNS
Barinthus Bio, Clywedog enter definitive merger agreement
PremiumThe FlyBarinthus Bio, Clywedog enter definitive merger agreement
10M ago
BRNS
Barinthus Biotherapeutics: Promising Clinical Developments and Strong Financial Position Justify Buy Rating
Premium
Ratings
Barinthus Biotherapeutics: Promising Clinical Developments and Strong Financial Position Justify Buy Rating
12M ago
BRNS
Barinthus Biotherapeutics Reports Q2 2025 Financial Results
Premium
Company Announcements
Barinthus Biotherapeutics Reports Q2 2025 Financial Results
12M ago
BRNS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >